tradingkey.logo

Ihuman Inc

IH
2.208USD
+0.045+2.07%
Market hours ETQuotes delayed by 15 min
566.85MMarket Cap
2.38P/E TTM

Ihuman Inc

2.208
+0.045+2.07%

More Details of Ihuman Inc Company

iHuman Inc is a holding company primarily engaged in the provision of tech-powered, intellectual development products for children. The products primarily include interactive and self-directed apps, offline products and others, as well as animated content and derivative offerings. The interactive and self-directed apps are offered under the brands iHuman bekids and Aha World. The apps primarily include iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHumanpedia, bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, Aha World and Aha Makeover. The Company is also engaged in the development of stimulating materials, including books, interactive materials and smart devices for children. The Company operates its businesses in the domestic market and overseas markets.

Ihuman Inc Info

Ticker SymbolIH
Company nameiHuman Inc
IPO dateOct 09, 2020
CEODai (Peng)
Number of employees723
Security typeDepository Receipt
Fiscal year-endOct 09
AddressFloor 8, Building 2
CityBEIJING
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryChina
Postal code100102
Phone861057806636
Websitehttps://www.ihuman.com/
Ticker SymbolIH
IPO dateOct 09, 2020
CEODai (Peng)

Company Executives of Ihuman Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Wenbin Lu
Mr. Wenbin Lu
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Hanfeng Chi
Mr. Hanfeng Chi
Director
Director
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Ms. Xuenan Li
Ms. Xuenan Li
Independent Director
Independent Director
--
--
Mr. Justin Zhang
Mr. Justin Zhang
IR Contact Officer
IR Contact Officer
--
--
Mr. Yufeng (Michael) Chi
Mr. Yufeng (Michael) Chi
Chairman of the Board
Chairman of the Board
--
--
Mr. Peng Dai
Mr. Peng Dai
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Weiwei (Vivien) Wang
Ms. Weiwei (Vivien) Wang
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Wenbin Lu
Mr. Wenbin Lu
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Hanfeng Chi
Mr. Hanfeng Chi
Director
Director
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Ms. Xuenan Li
Ms. Xuenan Li
Independent Director
Independent Director
--
--
Mr. Justin Zhang
Mr. Justin Zhang
IR Contact Officer
IR Contact Officer
--
--
Mr. Yufeng (Michael) Chi
Mr. Yufeng (Michael) Chi
Chairman of the Board
Chairman of the Board
--
--

Revenue Breakdown

FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
China (Mainland)
922.20M
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Morgan Stanley & Co. LLC
0.35%
Value Partners Ltd.
0.08%
Citadel Advisors LLC
0.07%
Acadian Asset Management LLC
0.07%
BNP Paribas Securities Corp. North America
0.02%
Other
99.40%
Shareholders
Shareholders
Proportion
Morgan Stanley & Co. LLC
0.35%
Value Partners Ltd.
0.08%
Citadel Advisors LLC
0.07%
Acadian Asset Management LLC
0.07%
BNP Paribas Securities Corp. North America
0.02%
Other
99.40%
Shareholder Types
Shareholders
Proportion
Research Firm
0.37%
Investment Advisor/Hedge Fund
0.15%
Hedge Fund
0.07%
Investment Advisor
0.02%
Other
99.39%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
24
178.76K
0.79%
-1.37M
2025Q2
22
252.94K
1.11%
-1.17M
2025Q1
22
272.94K
1.20%
-1.15M
2024Q4
20
157.66K
0.67%
-1.29M
2024Q3
21
145.31K
0.62%
-1.42M
2024Q2
20
1.39M
5.91%
-862.29K
2024Q1
20
2.12M
8.86%
-854.55K
2023Q4
20
2.71M
11.30%
-323.52K
2023Q3
26
2.74M
10.93%
-358.47K
2023Q2
29
2.73M
11.40%
-374.02K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Morgan Stanley & Co. LLC
85.60K
0.38%
-3.20K
-3.60%
Jun 30, 2025
Citadel Advisors LLC
35.39K
0.16%
-20.11K
-36.23%
Jun 30, 2025
Acadian Asset Management LLC
15.07K
0.07%
--
--
Jun 30, 2025
BNP Paribas Securities Corp. North America
4.00K
0.02%
--
--
Jun 30, 2025
Andbank Wealth Management, SGIIC, S.A.U.
2.82K
0.01%
+630.00
+28.78%
Jul 31, 2025
Aperio Group, LLC
320.00
0%
+320.00
--
Jun 30, 2025
EverSource Wealth Advisors, LLC
305.00
0%
+305.00
--
Jun 30, 2025
Axxion S.A.
--
0%
-20.00K
-100.00%
Apr 30, 2025
Rhumbline Advisers Ltd. Partnership
820.00
0%
-114.00
-12.21%
Jun 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
SPDR Portfolio Emerging Markets ETF
0%
SPDR Portfolio Emerging Markets ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data

FAQs

Who are the top five shareholders of Ihuman Inc?

The top five shareholders of Ihuman Inc are:
Morgan Stanley & Co. LLC holds 85.60K shares, accounting for 0.38% of the total shares.
Citadel Advisors LLC holds 35.39K shares, accounting for 0.16% of the total shares.
Acadian Asset Management LLC holds 15.07K shares, accounting for 0.07% of the total shares.
BNP Paribas Securities Corp. North America holds 4.00K shares, accounting for 0.02% of the total shares.
Andbank Wealth Management, SGIIC, S.A.U. holds 2.82K shares, accounting for 0.01% of the total shares.

What are the top three shareholder types of Ihuman Inc?

The top three shareholder types of Ihuman Inc are:
Morgan Stanley & Co. LLC
Value Partners Ltd.
Citadel Advisors LLC

How many institutions hold shares of Ihuman Inc (IH)?

As of 2025Q3, 24 institutions hold shares of Ihuman Inc, with a combined market value of approximately 178.76K, accounting for 0.79% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -0.32%.

What is the biggest source of revenue for Ihuman Inc?

In FY2024, the -- business generated the highest revenue for Ihuman Inc, amounting to -- and accounting for --% of total revenue.
KeyAI